Background
Frishman, William Howard was born on November 9, 1946 in New York City. Son of Aaron and Frances Frishman.
(Cardiovascular Pharmacotherapeutics: Abridged and Updated...)
Cardiovascular Pharmacotherapeutics: Abridged and Updated provides current, on-the-spot information on how to use every approved cardiovascular drug in adults and children, and the scientific rationale for their clinical use. A clinical distillation of the editors' comprehensive and highly respected Cardiovascular Pharmacotherapeutics 3rd edition textbook, this treatment-centered abridgement features: • Indications, contraindications, dosage, side effects, pharmacokinetics, and adverse reactions for all approved cardiovascular drugs, including the newest therapeutic agents to become available • Rationales and usage guidelines for cardiovascular therapeutic strategies • Abundant tables and charts that summarize important clinical choices • Handy appendices that review approved uses of cardiovascular agents and their pharmacologic characteristics • Considerations for managing patients on multi-drug regimens • Details on drug-drug interaction • Updated information on alternative medicine approaches to cardiovascular disease. This book is an abridged and updated version of Cardiovascular Pharmacotherapeutics. Compared to the hardcover 3rd edition, it excludes part 1 (with the exception of the first chapter), includes all of part 2, excludes part 3 (with the exception of chapters 30 and 31), and includes appendices 1 and 2; appendices 3-8 are excluded.
http://www.amazon.com/gp/product/1935395521/?tag=2022091-20
(EVERYTHING PRACTICING PHYSICIANS AND PHARMACISTS NEED TO ...)
EVERYTHING PRACTICING PHYSICIANS AND PHARMACISTS NEED TO KNOW ABOUT DRUG THERAPY FOR HEART CONDITIONS The updated Second Edition of this classic brings you fully up to speed on… All the cardiovascular agents now available Mechanisms of action of cardiovascular pharmacotherapeutics Specific drug treatments Drugs in development Molecular biological advances More A compendium of valuable, updated pharmacotherapeutic information for managing patients with cardiovascular disease Cardiovascular Pharmacotherapeutics has long been considered the primary reference for practicing physicians and pharmacists who need to know about drug therapy for heart conditions. This new Second Edition keeps pace with the latest drug discoveries and new therapeutic agents -- a task that challenges even specialists in the field. Contributions from many of the leading investigators in cardiovascular pathophysiology and drug development This timely second edition, primarily oriented toward specific drugs and drug classes, is co-edited and co-authored by three distinguished physician-scientists with important research accomplishments in cardiovascular pharmacology and pathophysiology. They provide you with: An understanding of all presently available cardiovascular agents The scientific basis behind every pharmacotherapy advance Hands-on discussions of how to utilize specific drugs for treatment of various cardiovascular disorders and for the prevention of disease Information about recently approved drugs that were only pharmacologic concepts in the previous edition Detailed discussion of drugs in development and potential drug targets for innovative drug discovery – outgrowths of advances in knowledge of receptor and ion channel biology, cell growth, neurohumoral control, biochemistry and pathophysiology More Significant Features of the Second Edition New section on New Drug Classes in Development keeps you abreast of this fast-evolving therapeutic area Special Topics section provides additional information on drug-drug interactions, the use of cardiovascular drugs in children, the treatment of peripheral vascular disease, complementary medicine, and quality of life issues Appendices provide you with practical, hands-on information on drug utilization in clinical practice
http://www.amazon.com/gp/product/B0091MKFS0/?tag=2022091-20
(EVERYTHING PRACTICING PHYSICIANS AND PHARMACISTS NEED TO ...)
EVERYTHING PRACTICING PHYSICIANS AND PHARMACISTS NEED TO KNOW ABOUT DRUG THERAPY FOR CARDIOVASCULAR DISEASE A critically acclaimed classic reference now in its third edition, Cardiovascular Pharmacotherapeutics, provides current information regarding the contemporary use of all available cardiovascular medications for adults and children. Strongly emphasizing the scientific rationale behind the use of such cardiovascular therapeutics, it discusses new drugs and novel compounds that are under development and may emerge as the cardiac therapies of the future. This edition also addresses special considerations for drug therapy use in the elderly, during pregnancy, and in those with hepatic or renal disease. A generous assortment of tables, figures, and appendices guides readers in their investigations of each drug group and various disease states. Contents: This edition is organized into 4 main sections. • The introductory section includes chapters related to relevant clinical pharmacology, the placebo effect in cardiovascular disease treatments, patient adherence to pharmacotherapy, and pharmacoeconomics. • The available cardiovascular drugs are reviewed, and each class of drugs is organized into separate chapters. In these chapters the reader will find detailed discussions on how to use individual drugs for prevention and treatment. New drugs in development for each class of agents are also reviewed. Compared to the first 2 editions, the editors have provided hundreds of updated reference citations, as well as adding new chapters on drugs for pulmonary hypertension, vasopressin and vasopressin antagonists, and drug-eluting stents. Since cardiovascular clinicians do not practice in a vacuum, there are also chapters in this section that deal with the pharmacotherapy of obesity, diabetes mellitus, and smoking cessation as it relates to the cardiac patient. • Special topics related to cardiovascular pharmacotherapy that the clinician will often encounter and includes chapters on alternative and complementary medicine, cardiovascular drug drug interactions, pediatric cardiovascular pharmacology, antibiotic prophylaxis and treatment guidelines for endocarditis and rheumatic fever, and drug therapy of cerebrovascular and peripheral vascular diseases. The section concludes with a chapter on cytokines and myocardial regeneration as a new therapeutic option for cardiac disease and a final chapter that summarizes the status of more than 200 agents that are currently in clinical trials as innovative treatments for cardiovascular disease. • 8-part appendix provides practical, hands-on information on using drugs in clinical settings. • Provides relevant pharmacokinetic information regarding all the available cardiovascular drugs. • Offers practical drug prescribing information. • Guides for using cardiovascular drugs in specific patient populations. This book features an accompanying website, Advances in Cardiovascular Pharmacotherapeutics(cvpct3.com), which highlights advances in cardiovascular drug therapy. Each chapter in the book is updated periodically online with links to new studies; the original chapter authors oversee the updates. In addition, new cardiovascular drugs approved for clinical use by the FDA are reviewed. Readers may communicate directly with the authors and editors through the website regarding topics related to cardiovascular drug use. Note that bibliographic references are not listed in the book but available online in the form of downloadable PDFs at cvpct3.com.
http://www.amazon.com/gp/product/0979016436/?tag=2022091-20
(This manual, based on the definitive reference, is a conc...)
This manual, based on the definitive reference, is a concise and portable guide to the pharmacologic management of cardiovascular conditions. Focused on clinically relevant information related to drug treatment, this book features tables and charts for quick reference.
http://www.amazon.com/gp/product/0071373632/?tag=2022091-20
(This four-colour reference book aims to provide up-to-dat...)
This four-colour reference book aims to provide up-to-date information for every prescriber of cardiovascular drugs. Each drug is outlined across one- or two-page spreads, presenting indications, contra-indications, side effects, drug interactions, pharmacokinetics, special precautions and dosage.
http://www.amazon.com/gp/product/1878132113/?tag=2022091-20
gerontologist Pharmacologist cardiology educator
Frishman, William Howard was born on November 9, 1946 in New York City. Son of Aaron and Frances Frishman.
Bachelor, Doctor of Medicine, Boston University, 1969.
Intern, Montefiore Hospital, Bronx, New York, 1969-1970; resident in medicine, Montefiore Hospital, Bronx, New York, 1970-1971; resident in medicine, Bronx Municipal and Einstein Hospitals, 1971-1972; fellow in cardiology, New York Hospital-Cornell Univercity Medical College, New York City, 1972-1974; instructor, New York Hospital-Cornell Univercity Medical College, New York City, 1974-1976; director noninvasive cardiac laboratories, Einstein Hospital and Montefiore Hospital, 1976-1980; director cardiology service, Einstein Hospital and Montefiore Hospital, 1980-1982; chief medicine, Einstein Hospital and Montefiore Hospital, 1982-1991; professor medicine and epidemiology, associate department chairman medicine, Albert Einstein College Medicine Yeshiva U., Bronx, 1991-1997; professor medicine and pharmacology, department chairman medicine, New York Medical College, Valhalla, since 1997; chief of medicine, Westchester Medical Center, Valhalla, New York, since 1997. Expert consultant cardiorenal division Food and Drug Administration, Bethesda, Maryland., since 1987. Panel mem.U.S. Pharmacopeial Convention, Rockville, Maryland., since 1990.
(EVERYTHING PRACTICING PHYSICIANS AND PHARMACISTS NEED TO ...)
(EVERYTHING PRACTICING PHYSICIANS AND PHARMACISTS NEED TO ...)
(Cardiovascular Pharmacotherapeutics: Abridged and Updated...)
(This manual, based on the definitive reference, is a conc...)
(This four-colour reference book aims to provide up-to-dat...)
Member fiscal affairs committee Village of Scarsdale, New York, since 1991. Lieutenant col.M.C., United States Army, 1969-1990. Fellow American College of Physicians, American College Cardiology (Board of Governors 1987-1991, president New York Statechpt.
1991), American College Chest Physicians. Member American Society for Clinical Pharmacology and Therapeutics (Mckeen Cattell award 1990), American Society for Clinical Research, New York Cardiol. Society (president 1996-1997), Scarsdale Town and Village Club, Alpha Omega Alpha (councillor).
Married Esther Rose Sandowsky, March 11, 1971. Children: Sheryl Renée, Amy Helene, Michael Aaron.